These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 8442777)
1. Inhibition of phospholipase A2 purified from human herniated disc. Carabaza A; Cabré F; García AM; Gómez M; Sánchez J; Mauleón D; Carganico G Biochem Pharmacol; 1993 Feb; 45(3):783-6. PubMed ID: 8442777 [TBL] [Abstract][Full Text] [Related]
2. Cellular and topical in vivo inflammatory murine models in the evaluation of inhibitors of phospholipase A2. Glaser KB; Sung ML; Hartman DA; Lock YW; Bauer J; Walter T; Carlson RP Skin Pharmacol; 1995; 8(6):300-8. PubMed ID: 8688196 [TBL] [Abstract][Full Text] [Related]
3. A controlled biochemical and immunohistochemical study of human synovial-type (group II) phospholipase A2 and inflammatory cells in macroscopically normal, degenerated, and herniated human lumbar disc tissues. Grönblad M; Virri J; Rönkkö S; Kiviranta I; Vanharanta H; Seitsalo S; Rashbaum RF; Guyer RD Spine (Phila Pa 1976); 1996 Nov; 21(22):2531-8. PubMed ID: 8961439 [TBL] [Abstract][Full Text] [Related]
4. Evaluation of antirheumatic drugs for their effect in vitro on purified human synovial fluid phospholipase A2. Marshall LA; Bauer J; Sung ML; Chang JY J Rheumatol; 1991 Jan; 18(1):59-65. PubMed ID: 2023201 [TBL] [Abstract][Full Text] [Related]
5. Inhibition studies on the membrane-associated phospholipase A2 in vitro and prostaglandin E2 production in vivo of the macrophage-like P388D1 cell. Effects of manoalide, 7,7-dimethyl-5,8-eicosadienoic acid, and p-bromophenacyl bromide. Lister MD; Glaser KB; Ulevitch RJ; Dennis EA J Biol Chem; 1989 May; 264(15):8520-8. PubMed ID: 2498315 [TBL] [Abstract][Full Text] [Related]
6. Human disc phospholipase A2 is inflammatory. Franson RC; Saal JS; Saal JA Spine (Phila Pa 1976); 1992 Jun; 17(6 Suppl):S129-32. PubMed ID: 1631712 [TBL] [Abstract][Full Text] [Related]
7. Inactivation of human synovial fluid phospholipase A2 by the marine natural product, manoalide. Jacobson PB; Marshall LA; Sung A; Jacobs RS Biochem Pharmacol; 1990 May; 39(10):1557-64. PubMed ID: 2337412 [TBL] [Abstract][Full Text] [Related]
8. The effects of the phospholipase A2 inhibitor, manoalide, on cartilage degradation, stromelysin expression, and synovial fluid cell count induced by intraarticular injection of human recombinant interleukin-1 alpha in the rabbit. Schrier DJ; Flory CM; Finkel M; Kuchera SL; Lesch ME; Jacobson PB Arthritis Rheum; 1996 Aug; 39(8):1292-9. PubMed ID: 8702436 [TBL] [Abstract][Full Text] [Related]
9. Groups I, II and III extracellular phospholipases A2: selective inhibition of group II enzymes by indomethacin but not other NSAIDs. Lobo IB; Hoult JR Agents Actions; 1994 Mar; 41(1-2):111-3. PubMed ID: 8079814 [TBL] [Abstract][Full Text] [Related]
10. Differential effects of manoalide on secreted and intracellular phospholipases. Bennett CF; Mong S; Clarke MA; Kruse LI; Crooke ST Biochem Pharmacol; 1987 Mar; 36(5):733-40. PubMed ID: 3103628 [TBL] [Abstract][Full Text] [Related]
11. Antiflammin-2 (HDMNKVLDL) does not inhibit phospholipase A2 activities. Hope WC; Patel BJ; Bolin DR Agents Actions; 1991 Sep; 34(1-2):77-80. PubMed ID: 1793057 [TBL] [Abstract][Full Text] [Related]
12. PX-52, A novel inhibitor of 14 kDa secretory and 85 kDa cytosolic phospholipases A2. Franson RC; Rosenthal MD Adv Exp Med Biol; 1997; 400A():365-73. PubMed ID: 9547578 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of human non-pancreatic phospholipases A2 by retinoids and flavonoids. Mechanism of action. Fawzy AA; Vishwanath BS; Franson RC Agents Actions; 1988 Dec; 25(3-4):394-400. PubMed ID: 3218613 [TBL] [Abstract][Full Text] [Related]
14. Comparative immunohistochemical study of group II (synovial-type) and group IV (cytosolic) phospholipases A2 in disc prolapse tissue. Habtemariam A; Grönblad M; Virri J; Airaksinen O; Luukkonen M; Turunen V; Savolainen S; Karaharju E Eur Spine J; 1998; 7(5):387-93. PubMed ID: 9840472 [TBL] [Abstract][Full Text] [Related]
15. Retinoids inhibit phospholipase A2 in human synovial fluid and arachidonic acid release from rat peritoneal macrophages. Hope WC; Patel BJ; Fiedler-Nagy C; Wittreich BH Inflammation; 1990 Oct; 14(5):543-59. PubMed ID: 2123476 [TBL] [Abstract][Full Text] [Related]
16. Phospholipase A2 activity in herniated lumbar discs. Clinical correlations and inhibition by piroxicam. Piperno M; Hellio le Graverand MP; Reboul P; Mathieu P; Tron AM; Perrin G; Peschard MJ; Richard M; Vignon E Spine (Phila Pa 1976); 1997 Sep; 22(18):2061-5. PubMed ID: 9322315 [TBL] [Abstract][Full Text] [Related]
17. High levels of inflammatory phospholipase A2 activity in lumbar disc herniations. Saal JS; Franson RC; Dobrow R; Saal JA; White AH; Goldthwaite N Spine (Phila Pa 1976); 1990 Jul; 15(7):674-8. PubMed ID: 2218714 [TBL] [Abstract][Full Text] [Related]
18. Inactivation of phospholipase A2 by manoalide. Localization of the manoalide binding site on bee venom phospholipase A2. Glaser KB; Vedvick TS; Jacobs RS Biochem Pharmacol; 1988 Oct; 37(19):3639-46. PubMed ID: 3178877 [TBL] [Abstract][Full Text] [Related]
19. Immunochemical relatedness between secretory phospholipase A2 and intracellular phospholipase A2 activity linked with arachidonic acid mobilization in macrophages. Lloret S; Moreno JJ Toxicon; 1994 Nov; 32(11):1327-36. PubMed ID: 7886692 [TBL] [Abstract][Full Text] [Related]
20. Biochemical characterization of soluble phospholipase A2 from rheumatoid synovial fluid. Gonzalez-Buritica H; Smith DM; Turner RA Agents Actions; 1989 Jun; 27(3-4):477-80. PubMed ID: 2508447 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]